COMPREHENSIVE APPROACH TO SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK FROM BIOLOGY TO CLINIC. QUINTA EDIZIONE
Evento Residenziale ECM
Presidente del Congresso: Franco Ionna
Responsabili Scientifici: Francesco Perri, Morena Fasano, Francesco Longo
Sede dell'evento: NH Panorama - Napoli
Data dell'evento: 25/26 giugno 2026
Programma ECM
Giovedì, 25 giugno 2026
9:00 – Meeting Presentation – Prof. Francesco Perri, Prof.ssa Morena Fasano, Prof. Francesco Longo
9:10 – Great of the Authorities – The importance of Site-Site Collaboration for Academic Research
• Dr. Maurizio Di Mauro (Direttore Generale INT IRCCS Fondazione G. Pascale);
• Prof. Fortunato Ciardiello (Direttore Oncologia Università Vanvitelli);
• Prof. Alfredo Budillon (Direttore Scientifico INT IRCCS Fondazione G. Pascale)
• Prof. Giordano Beretta (Presidio Ospedaliero di Pescara)
• Prof. Franco Maria Buonaguro (INT IRCCS Foundation G Pascale, Naples)
SESSION I – EARLY DIAGNOSIS OF ORAL CAVITY CANCER: WHAT’S NEW?
Chairmen: Dr. Umberto Esposito, Dr. Salvatore Alfieri, Dr. Filippo Ricciardiello
9:30 – Diagnosis of OPDM: early symptoms and features – Dr. ssa Petra Claudia Camilla D’Orsi
9:45 – Management of OPDM: guidelines for optimal framing – Dr. Agostino Guida
10:00 – OPMD: pathological features – Dr. Gerardo Ferrara
10:15 – Alternative therapies for OPMD: the role of clinical Trials – Dr. Carlo Resteghini
10:30 – Discussion – Chairmen: Dr. Umberto Esposito, Dr. Salvatore Alfieri, Dr. Filippo Ricciardiello
SESSION II – EARLY DIAGNOSIS AND IMAGING SUPPORT IN SCCHN
Chairmen: Prof.ssa Maria Paola Belfiore, Dr. Raffaele Addeo
11:00 – Early diagnosis of Oral Cavity Lesion: the role of ultrasonography – Dr. Dario Di Stasio
11:15 – TC, MRI or integration? A crucial tool – Dr.ssa Irma Palescandolo
11:30 – Discussion – Chairmen: Prof.ssa Maria Paola Belfiore, Dr. Raffaele Addeo
SESSION III – LOCALLY ADVANCED SCCHN: UPDATES AND DASHED WHISHES
Chairmen: Prof. Claudio Caporale, Prof. Giovanni Dell’Aversana Orabona, Dr. Matteo Muto
12:00 – Surgical Management of advanced Oral Cavity Cancer: the role of reconstructive Surgery – Prof.ssa Chiara Copelli
12:15 – Conservative Strategies in Locally Advanced SCCHN: what indications? – Dr.ssa Irene De Santo
12:30 – The role of Induction Therapy in SCCHN: status of the art and future perspectives – Dr.ssa Loredana Palermo
12:45 – Clinical experience and “response from the audience” – Dr. Pierre Guarino
13:30 – Lunch
SESSION IV – ROLE OF SUPPORTIVE THERAPY IN SCCHN MANAGEMENT
Chairmen: Prof. Giordano Beretta, Prof. Marco Cascella, Dr.ssa Valeria Turrà
14:30 – Malnutrition in patients with SCCHN: a very common feature – Dr.ssa Ileana Parascandolo
14:45 – Neoplastic cachexia: no way out - Dr. Vincenzo Zurlo
15:00 – Pain assessment in patients with SCCHN: what to do? – Dr.ssa Federica Monaco
15:15 – Antithrombotic prophylaxis in cancer patients: high risk in patients with SCCHN – Dr.ssa Matilde Pensabene
15:30 – Iron Supplementation and liver protection: supportive therapy or something more? – Dr.ssa Maria Chiara Cau
15:45 – Speech therapy and timing: a wall – Dr.ssa Marta Spampinato
16:00 – Importance of Drug-Drug Interaction assessment in the clinical practice – Dr.ssa Maria Luisa Marciano
16:15 – Clinical Case and “response from the audience” - Dr.ssa Arianna Piccirillo
16:30 – Discussion – Chairmen: Prof. Giordano Beretta, Prof. Marco Cascella, Dr.ssa Valeria Turrà
Venerdì, 26 giugno 2026
SESSION V – ADVANCED DISEASE AND MTD: THE KEYSTONE
Chairmen: Prof. Morena Fasano, Dr. Livio Blasi, Dr. Giuseppe Tortoriello
9:00 – The Role of Radiation Therapy in Recurrent/Metastatic Disease – Prof.ssa Francesca De Felice
9:15 – Systemic therapies and identification of the correct sequences – Dr.ssa Marianna Caterino
9:30 – Immunotherapy, Check-Point Inhibitors and…. CAR-T cells? – Dr.ssa Agata Laudani
9:45 – The Evolving Role of Electrochemotherapy in SCCHN – Prof. Francesco Longo
10:00 – Clinical Case and “response from the audience” – Dr.ssa Erica Perri
SESSION VI – FUTURE PERSPECTIVES AND TAKE HOME MESSAGE
11:00 – Promising Drugs in SCCHN: the role of bispecific antibodies – Prof. Paolo Bossi
11:20 – Open Clinical Trials in Italy and how to better perform – Prof. Francesco Perri
11:40 – Future options with subcutaneous ICI: the experience of Malignant Melanoma – Dr.ssa Margaret Ottaviano
12:00 – Discussion – Prof. Paolo Bossi, Prof. Franceco Perri
SESSION VII – TRANSLATIONAL INSIGHT IN SCCHN: A “RECENT” ERA
Chairmen: Prof. PieroSandro Tagliaferri, Prof. Francesco Sabbatino, Prof. Michele Caraglia
12:30 – HPV Related SCCHN: what is changed? - Dr.ssa Maria Lina Tornesello
12:45 – NPC and Nasopharyngeal Carcinoma: therapeutic implications – Dr. Alessio Cirillo
13:00 – Recurrent/Metastatic Thyroid carcinoma status of the art: the crucial support of Translational Research – Dr.ssa Daria Maria Filippini
13:15 – What have we learned from translational research in SCCHN? – Prof. Marco Carlo Merlano
13:35 – Discussion – Chairmen: Prof. Piero Sandro Tagliaferri, Prof. Francesco Sabbatino, Prof. Michele Caraglia
Italian Medical Research
Provider ECM n°1344 accreditato presso il Ministero della Salute - Age.na.s
Per qualsiasi comunicazione e/o supporto:
- 0824 23156
- italianmr.com
- assistenza@italianmr.com
- Leggi le FAQ
Per consultare la nostra lista di Corsi ECM: